patent pool

Vaccinating the poorest half of humanity —3.7 billion people— against coronavirus could cost less than what the ten biggest pharmaceutical companies make in four months, Oxfam said today. 

Governments which have failed to pay their contributions to the Global Fund to Fight AIDS, Malaria and Tuberculosis are guilty of breaking their own promise to extend HIV treatment just months after they made it, Oxfam said today.

Oxfam today praised the Medicine Patent Pool (MPP) for securing the first licenses for HIV medicines with the pharmaceutical company Gilead, a move that will boost the affordability and eff

Oxfam today welcomed an agreement between the UNITAID-backed Medicine Patent Pool Foundation (MPPF) and the US National Institutes of Health (NIH) to license the antiretroviral drug darunavir to the patent pool. The pool was set up to reduce the cost of HIV medicines.